Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Early Neutralizing Antibodies in Infants Living With HIV to Enhance Their Life 1
PACTR202607574273305Phase 2Not yet recruiting
- Sponsor
- Fundación para la Investigación Biomédica del Hospital 12 de Octubre
- Start
- Jan 2027
- Countries
- 1
01
Overview
Phase 2 trial in Human immunodeficiency virus infection type 1 (2 arms), sponsored by Fundación para la Investigación Biomédica del Hospital 12 de Octubre. Planned start Jan 2027; status: not yet recruiting.
02
Conditions
Human immunodeficiency virus infection type 1
Beyond the preview
Go deeper on PACTR202607574273305.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202607574273305.